Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers

被引:207
作者
Kozminski, Przemyslaw [1 ]
Halik, Pawel Krzysztof [1 ]
Chesori, Raphael [1 ]
Gniazdowska, Ewa [1 ]
机构
[1] Inst Nucl Chem & Technol, Ctr Radiochem & Nucl Chem, Dorodna 16, PL-03195 Warsaw, Poland
关键词
methotrexate; myasthenia gravis; Alzheimer's disease; immunosuppressive drug; disease modifying anti-rheumatic drug; anticancer drug; HIGH-DOSE METHOTREXATE; CENTRAL-NERVOUS-SYSTEM; ACUTE LYMPHOBLASTIC-LEUKEMIA; SINGLE-AGENT METHOTREXATE; SQUAMOUS-CELL CARCINOMA; NEGATIVE BREAST-CANCER; GESTATIONAL TROPHOBLASTIC NEOPLASIA; TREAT MYCOSIS-FUNGOIDES; ADVANCED BLADDER-CANCER; BLOOD-BRAIN-BARRIER;
D O I
10.3390/ijms21103483
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Methotrexate, a structural analogue of folic acid, is one of the most effective and extensively used drugs for treating many kinds of cancer or severe and resistant forms of autoimmune diseases. In this paper, we take an overview of the present state of knowledge with regards to complex mechanisms of methotrexate action and its applications as immunosuppressive drug or chemotherapeutic agent in oncological combination therapy. In addition, the issue of the potential benefits of methotrexate in the development of neurological disorders in Alzheimer's disease or myasthenia gravis will be discussed.
引用
收藏
页数:38
相关论文
共 315 条
[1]   Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy [J].
Abdelrady, Hend ;
Hathout, Rania M. ;
Osman, Rihab ;
Saleem, Imran ;
Mortada, Nahed D. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 133 :115-126
[2]  
Abdou AM, 2007, NEUROLOGY, V68, pA300
[3]   Treatment for low-risk gestational trophoblastic disease: Comparison of single-agent methotrexate, dactinomycin and combination regimens [J].
Abrao, Renato Antonio ;
de Andrade, Jurandyr Moreira ;
Tiezzi, Daniel Guimaraes ;
Cosiski Marana, Heitor Ricardo ;
Candido dos Reis, Francisco Jose ;
Clagnan, Willian Simoes .
GYNECOLOGIC ONCOLOGY, 2008, 108 (01) :149-153
[4]   Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia [J].
Agarwal, R. ;
Harding, V. ;
Short, D. ;
Fisher, R. A. ;
Sebire, N. J. ;
Harvey, R. ;
Patel, D. ;
Savage, P. M. ;
Lim, A. K. P. ;
Seckl, M. J. .
BRITISH JOURNAL OF CANCER, 2012, 106 (06) :1089-1094
[5]   VINBLASTINE AND METHOTREXATE FOR ADVANCED BLADDER-CANCER [J].
AHMED, T ;
YAGODA, A ;
NEEDLES, B ;
SCHER, HL ;
WATSON, RC ;
GELLER, N .
JOURNAL OF UROLOGY, 1985, 133 (04) :602-604
[6]  
Al-Anazi KA, 2009, CLIN MED INSIGHT-CAS, V2, P43
[7]   Epidemiology of adult rheumatoid arthritis [J].
Alamanos, Y ;
Drosos, AA .
AUTOIMMUNITY REVIEWS, 2005, 4 (03) :130-136
[8]   Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia [J].
Alazzam, Mo'iad ;
Tidy, John ;
Osborne, Raymond ;
Coleman, Robert ;
Hancock, Barry W. ;
Lawrie, Theresa A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01)
[9]   INHIBITION OF PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE TRANSFORMYLASE BY METHOTREXATE AND DIHYDROFOLIC ACID POLYGLUTAMATES [J].
ALLEGRA, CJ ;
DRAKE, JC ;
JOLIVET, J ;
CHABNER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (15) :4881-4885
[10]  
ALLEGRA CJ, 1985, J BIOL CHEM, V260, P9720